Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) Shares Outstanding (Diluted Average) (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Shares Outstanding (Diluted Average) for 3 consecutive years, with $10.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Outstanding (Diluted Average) rose 235.48% year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Jun 2025, up 235.48%, and an annual FY2024 reading of $3.7 million, up 331.88% over the prior year.
  • Shares Outstanding (Diluted Average) was $10.0 million for Q2 2025 at SeaStar Medical Holding, up from $8.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $13.0 million in Q1 2023 and bottomed at $559385.0 in Q2 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $4.7 million, with a median of $3.4 million recorded in 2024.
  • Peak annual rise in Shares Outstanding (Diluted Average) hit 431.88% in 2024, while the deepest fall reached 79.39% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $866813.0 in 2023, then soared by 331.88% to $3.7 million in 2024, then skyrocketed by 166.62% to $10.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ICU at $10.0 million in Q2 2025, $8.6 million in Q1 2025, and $3.7 million in Q4 2024.